News
Extending their winning streak for the fifth straight session, Indian stock market benchmarks — the Sensex and Nifty 50 — closed with modest ga ...
Business Intelligence | From W.D. Strategies on MSN22m
Unlocking the Power of Semrush AI Analytics: A Complete Guide to Smarter Market Intelligence
AI is changing search, and we discuss one of our firm's favorite tools for tracking brand performance and sentiment across the different LLMs, like ChatGPT, Perplexity, and Gemini.
Even several years ago, cryptocurrency trading was completely different. In its early years, traders made their decisions after doing technical analysis and fundamental research. A dramatic ...
Sentiment trends in U.S. stocks toward the end of summer are very different to those observed in May. VIX, the volatility or ‘fear’ index, is starting to trend higher while stock market momentum fades ...
1h
Cryptopolitan on MSNPi Network Price Prediction 2025–2031: Will Pi Recover or Crash?
The Pi Network is experiencing a wave of uncertainty as 268.4 million Pi tokens were unlocked in July 2025, marking the ...
With the stock currently trading at Rs 58.65, Suzlon Energy has experienced a decline, reflecting the overall bearish sentiment in the market.
The local sharemarket surges nearly 23 per cent from its April lows in an unprecedented move which shocks fund managers.
The benchmark equity indices traded higher on Thursday, supported by gains in Reliance Industries and banking stocks along with firm Asian cues. At 10:45 am, the 30-share BSE Sensex advanced 352.94 ...
Nifty and Sensex opened higher on Thursday as global positive cues and favourable developments related to GST reforms maintained positive sentiment across the market. Nifty 50 opened 91 points higher ...
On Wednesday, benchmark indices extended their winning streak for the fifth consecutive session, with the Sensex gaining 213 points and the Nifty advancing by 70 points. The gains were primarily led ...
Futu posted GAAP earnings per ADS of $2.32, beating expectations by $0.57. Revenue topped $676.6 million, up by 69.7% from ...
The first half of 2025 was brutal for biotech, but investors are still keen on therapeutics in several indications and silver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results